Amy Brenner, MD & Associates
6413 Thornberry Court · Mason, OH 45040
4.6(604 Google reviews · 53 in past year)
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
6413 Thornberry Court · Mason, OH 45040
4.6(604 Google reviews · 53 in past year)
5240 Socialville-Foster Road · Mason, OH 45040
4.3(182 Google reviews · 6 in past year)
7558 Central Parke Boulevard · Mason, OH 45040
4.7(165 Google reviews · 16 in past year)
6404 Thornberry Court · Mason, OH 45040
4.9(93 Google reviews · 6 in past year)
5160 Socialville-Foster Road · Mason, OH 45040
5.0(62 Google reviews · 3 in past year)
5740 Gateway Boulevard · Mason, OH 45040
4.8(59 Google reviews · 15 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Mason or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 3 of the 8 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Ohio residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.